SFSIG
AGN

San Francisco Sentry Investment Group’s Allergan Inc AGN Stock Holding History

San Francisco Sentry Investment Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-947
Closed -$201K – 165
2014
Q4 		$201K Buy
947
+22
+2% +$4.38K 0.12% 147
2014
Q3 		$165K Buy
925
+125
+16% +$20.8K 0.08% 174
2014
Q2 		$135K Hold
800
– – 0.06% 199
2014
Q1 		$99K Hold
800
– – 0.03% 268
2013
Q4 		$89K Hold
800
– – 0.03% 270
2013
Q3 		$72K Hold
800
– – 0.03% 275
2013
Q2 		$67K Buy
+800
New +$83K 0.02% 284

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

San Francisco Sentry Investment Group's AGN Position: Q1 2015 in Review

San Francisco Sentry Investment Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 947 shares — an estimated $201K sold.

San Francisco Sentry Investment Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $201K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • San Francisco Sentry Investment Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 947 Allergan Inc shares in Q1 2015, an estimated $201K.
  • San Francisco Sentry Investment Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • San Francisco Sentry Investment Group's Allergan Inc position peaked at $201K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2015, filed 7 May 2015.